Matching slides 7,851
Current window 2,491-2,520
Pages 262
Rows per page 30
Component: Otherclear collectionreset all

Component

2,491-2,520 of 7,851

filter-aware
09
Uses before-after comparison of corporate messaging and press releases to demonstrate a weakening value proposition.Enfusion, Inc. (ENFN) · Spruce Point Capital Management
Research note Short seller Beat · Call to AdventureLoop · Zoom In1 hit
164
The slide uses a 'before-after' or 'contradiction' framing to undermine the credibility of the company's product announcement.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
43
Uses a red box and arrow to visually emphasize the missing data point in the Viterra table compared to the Bunge table.Bunge Global SA (BG) · Ben Axler
Activist deck Short seller Beat · Evidence & ProofLoop · Before After1 hit
63
Uses a table to show historical shareholder percentages and highlights the 'Decaying insider alignment' trend.Bunge Global SA (BG) · Ben Axler
Activist deck Short seller Beat · Evidence & ProofLoop · Tale Two Worlds1 hit
157
Includes direct quotes from former BLI scientists as evidence of competitive displacement.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
09
The slide uses investigative channel checks to debunk a company's growth narrative.Caesarstone Ltd. (CSTE) · 57_Viceroy_Research
Research note Short seller Beat · Expose ContradictionLoop · Analogy1 hit
35
The slide uses a 'back-testing' methodology against Australian data to validate the discrepancy in US revenue figures.Caesarstone Ltd. (CSTE) · 57_Viceroy_Research
Research note Short seller Loop · Mece Breakdown1 hit
54
This is a slide from a short-seller activist report (likely Scorpion Capital).Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Expose Contradiction1 hit
32
The slide uses a narrative of past professional failure to cast doubt on current leadership.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
47
The slide uses direct quotes from two different medical professionals to highlight a pattern of disregard for safety protocols.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
11
The slide uses a 'villain' framing by calling IonQ a scam and quantum computing a 'science fiction fantasy'.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Problem with IonQ's Technology1 hit
96
The slide uses a 'quote-and-critique' structure to expose hypocrisy.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
131
The slide uses highlighted text to emphasize key technical criticisms regarding scaling and fidelity.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
103
The slide uses a Q&A format to highlight technical flaws in the light source technology.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
04
The slide outlines a forensic accounting argument regarding the manipulation of inventory and balance sheet items to artificially boost profit margins.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · Situation & ContextLoop · Aha Moment1 hit
21
The slide uses anecdotal evidence from a 'longtime executive' to frame Nevro as deceptive.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle1 hit
58
Uses excerpts from a press release and a clinical paper to highlight study design flaws.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit
118
The slide uses direct quotes from consultants to substantiate claims of corporate misconduct.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
140
Uses expert testimony to undermine company narrative regarding product success.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
157
Uses red boxes to highlight 'diabetic neuropathy' or 'peripheral neuropathy' in various insurance policy documents.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
212
Includes a pull-quote from an ex-Nevro consultant and a snippet from a DOJ press release.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
17
The slide uses a testimonial to establish credibility for the critique and links the founder to questionable research (algae electricity) to undermine his reputation.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
36
The slide uses a red box to highlight the source text and an arrow to emphasize the aggressive quote.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
74
The slide uses a 'callout' style block quote to highlight expert testimony, framing the company's data as cherry-picked.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
100
Uses a screenshot of a competitor's slide to highlight a lack of transparency in data reporting.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
101
Uses a calculation based on surface area and capacity density derived from a competitor's slide to expose a technical limitation.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
103
Uses expert testimony to debunk specific technical claims made by a competitor (QS).QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
128
Uses a direct quote from a CEO interview to highlight a potential contradiction or deception.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
164
The slide uses an external industry standard (Joule Battery Checklist) as a benchmark to critique the target company's lack of transparency.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
21
The slide uses a direct quote from the Pediatric Endocrine Society guidelines to expose the company's failure to address known side effects in their trial design.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit